Cost in perspective: direct assessment of American market acceptability of Co-60 in gynecologic high-dose-rate brachytherapy and contrast with experience abroad.
Mailhot Vega RB Jr, Barbee D, Talcott W, Duckworth T, Shah BA, Ishaq OF, Small C, Yeung AR, Perez CA, Schiff PB, Ginsburg O, Small W, Abdel-Wahab M, Bardales GS, Harkenrider M.
Mailhot Vega RB Jr, et al.
J Contemp Brachytherapy. 2018 Dec;10(6):503-509. doi: 10.5114/jcb.2018.79928. Epub 2018 Dec 28.
J Contemp Brachytherapy. 2018.
PMID: 30662472
Free PMC article.